Hans Knapp

Hans co-founded Yaletown in 2001 and brings over 20 years of investing, legal and corporate governance experience to Yaletown’ team.

A seasoned investor with multiple $200M+ exits under his belt, Hans manages Yaletown’s emerging-growth investments in Circle Cardiovascular, EPact Systems, Cooledge Lighting, Redlen Technologies and Equicare Health. Hans has played a key role in the formation, financing or exiting of over two dozen high growth companies, including Monexa’s sale to Netsuite (2015), Bitstew’s sale to General Electric (2016) and the sale of Daiya Foods to Otsuka Pharmaceuticals (2017).

Hans is the Vice Chair of the Board of the Canadian Venture Capital Association and a member of the Executive Committee of the CVCA. Prior to founding Yaletown Hans practiced commercial litigation with a leading national firm.

Yaletown invests in emerging-growth technology companies in Canada that enhance productivity and sustainability for enterprise and industrial customers. Yaletown’s investments help Canadian technology companies in their initial growth phase to accelerate their growth, shorten exit timeframes and achieve strong exit premiums.

With offices in Vancouver and Calgary, Yaletown is led by a team that brings together industry relationships and more than 120 years collective experience building and financing technology companies. Yaletown is backed by leading institutional investors in Canada and the United States, and by a network of successful technology entrepreneurs, executives, and angel investors. Yaletown leverages its network to seek out the most promising technology companies for investment.